Fundraising Fox
Charco Neurotech
Founded 2019 · 74 employees on LinkedIn · 8 known investors
Find your way into Charco Neurotech
Sign up to see every warm intro you have to Charco Neurotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Charco Neurotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Charco Neurotech develops the CUE1, a non-invasive device that uses vibratory stimulation to ease movement symptoms and improve quality of life for people with Parkinson's disease. The company builds its technology together with and for Parkinson's patients based on ongoing scientific research.
Investors · 8
How we know: Amadeus Capital Partners's portfolio page · a partner's Signal profile · funding news · imperial.ac.uk · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Cambridge Angels group's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: New Wave Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: amadeuscapital.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: imperial.ac.uk · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$10M disclosed across 1 round · 2021
- $10MseedNov 2021 · 3 sources
Amadeus Capital Partners (lead), Parkwalk Advisors (lead), Crista Galli Ventures, Imperial College Innovation Fund, MINT Venture Partners, University of Tokyo Edge Capital Partners (UTEC)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Charco Neurotech do?
- Charco Neurotech develops the CUE1, a non-invasive device that uses vibratory stimulation to ease movement symptoms and improve quality of life for people with Parkinson's disease. The company builds its technology together with and for Parkinson's patients based on ongoing scientific research.
- Who are Charco Neurotech's investors?
- Charco Neurotech's investors include Amadeus Capital Partners, Cambridge Angels group, New Wave Ventures, UTEC, Crista Galli Ventures, Parkwalk Advisors.
- How much funding has Charco Neurotech raised?
- Charco Neurotech has disclosed $10M raised across 1 round.